Orthopedics Private Equity – Market Update

Orthopedic Market Update Q1 2026

Private equity investment in orthopedics – initially catalyzed by Frazier Healthcare Partners’ formation of HOPCo in 2016 – has continued to mature and expand. As of early 2026, more than fifteen private equity–backed orthopedic platforms are operating across the United States, underscoring the specialty’s sustained appeal to institutional capital.

While broader healthcare M&A volumes contracted in 2025 amid elevated interest rates, tighter credit markets, and regulatory scrutiny, orthopedics demonstrated relative resilience. The sector benefits from durable demographic tailwinds, including population aging and increasing musculoskeletal disease prevalence, which continue to support procedural volume growth. Orthopedics also maintains attractive unit economics driven by high-acuity case mix, ancillary capture (imaging, PT, ASC participation), and favorable commercial payor exposure relative to primary care–oriented specialties.

Platform formation has also persisted despite broader market deceleration. In late 2024, OrthoNY launched as a new orthopedic platform in the Northeast, further reinforcing continued sponsor conviction in the space. Additionally, Physician Growth Partners advised Fox Valley Orthopedics on its partnership with Sequel Ortho, which closed on October 31, 2025.

Strategically, sponsor-backed orthopedic platforms are increasingly focused on driving regional density through disciplined add-on acquisitions within defined MSAs. Consolidation strategies are centered on enhancing referral capture, ASC utilization, physician recruitment, and ancillary penetration. Scale-driven synergies include supply chain optimization, revenue cycle infrastructure build-out, payor contracting leverage, and shared services centralization.

Capital deployment is also being directed toward technology-enabled differentiation. Investments in robotic-assisted surgery, AI-driven diagnostics, and 3D-printed customized implants are improving procedural precision and clinical outcomes while supporting market share gains in competitive geographies. Importantly, private equity ownership structures provide the capital and operational infrastructure required to absorb these investments without pressuring physician liquidity.

From a value creation perspective, sponsors are underwriting growth through:

• Incremental provider recruitment and productivity optimization
• Expansion of ancillary service lines and ASC ownership participation
• Commercial payor rate renegotiation
• Strategic tuck-in acquisitions to enhance geographic clustering

Current Orthopedic Landscape

While strategies vary by sponsor and platform, many private equity–backed orthopedic groups have driven measurable value through physician recruitment, ancillary service line expansion, payor rate optimization, and disciplined geographic growth. Increased scale provides enhanced purchasing power and operational leverage, supporting cost efficiencies while strengthening negotiating positions with payors and hospital systems. In parallel, several platforms are actively positioning their practices to adapt to the industry’s gradual transition toward value-based care models.

As orthopedic groups evaluate potential private equity and strategic partnerships, cultural alignment remains as critical as valuation. Platform structures and operating philosophies differ meaningfully, making it essential for physicians to assess factors such as clinical autonomy, integration approach, management fee structures, governance rights, and long-term strategic vision. Thoughtful partner selection is fundamental to building a durable, value-accretive relationship over time.

Recent Orthopedic Transactions

*PGP served as Exclusive Advisor to Fox Valley Orthopedics

About Our Firm

Physician Growth Partners (PGP) Physician Growth Partners (PGP) is an advisory firm working exclusively with independent physician groups in transactions with private equity.

PGP has completed 12 transactions in the last 12 months. Our firm is differentiated by:

• Senior partner involvement at every stage of the process
• Extensive physician practice transaction experience
• Unmatched relationships with all key private equity and strategic buyers interested in Orthopedics.